Could AI improve treatments for cancer patients? New IMI project OPTIMA thinks so
OPTIMA aims to use artificial intelligence (AI) to improve treatments for people with breast, lung and prostate cancer.
Site Search
Site Search
Displaying results 11 - 20 of 893
Tuberculosis projects represent the biggest ever funding effort to combat the disease
Almost €400 million has been invested by IMI through two projects, ERA4TB and UNITE4TB, to find new treatments for TB, the second-most fatal infectious disease after COVID19.
PRIMAVERA spotlights novel treatments to fight antimicrobial resistance
Vaccines and monoclonal antibodies could help fight AMR. The PRIMAVERA project will develop models to help identify which ones should be prioritised for development.
Two-dose Ebola vaccine is safe, induces robust immune response in adults with HIV
Data supports the IMI/Johnson and Johnson vaccine regimen as a preventative against Ebola in risk areas.
New IMI project Screen4Care to speed up diagnosis for rare disease patients
Screen4Care will use the genetic screening of newborn babies and artificial intelligence tools to accelerate the diagnosis of rare diseases, a process that currently takes years.
Quality matters: making sure research data is fit for its intended use
The EQIPD team developed a wiki-based quality system to help increase adherence to rigorous, evidence-based practices in preclinical research. Interview with Malcolm McLeod
New project RealHOPE asks how we handle protein-based drugs
If handled incorrectly, medicines based on proteins are easily broken down, risking their safety and efficacy. New IMI project RealHOPE aims to address the issue.
A mock ATM and a game of hide-and-seek? Testing gadgets and apps to track brain health
RADAR-AD are experimenting with different devices and software to track functional and cognitive decline in Alzheimer’s.
EPND
European Platform for Neurodegenerative Diseases
PRIMAVERA
Predicting the impact of monoclonal antibodies & vaccines on antimicrobial resistance